Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 04-12-2025
NAV ₹40.35(R) +0.25% ₹43.61(D) +0.25%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 3.75% 26.8% 18.7% 22.09% -%
Direct 4.63% 27.91% 19.76% 23.35% -%
Nifty Pharma TRI 3.12% 21.61% 14.04% 15.04% 7.75%
SIP (XIRR) Regular 9.67% 24.08% 20.3% 22.59% -%
Direct 10.61% 25.18% 21.33% 23.74% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.25 0.65 1.03 8.8% 0.22
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.74% -15.96% -15.77% 0.89 11.35%
Fund AUM As on: 30/06/2025 5378 Cr
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -

NAV Date: 04-12-2025

Scheme Name NAV Rupee Change Percent Change
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option 23.54
0.0600
0.2600%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option 26.34
0.0700
0.2700%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 40.35
0.1000
0.2500%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option 43.61
0.1100
0.2500%

Review Date: 04-12-2025

Beginning of Analysis

The Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has shown an excellent past performence in Pharma Fund. The Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Jensen Alpha of 8.8% which is higher than the category average of 4.59%. Here the Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has shown very good performance in terms of risk adjusted returns. The Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has a Sharpe Ratio of 1.25 which is higher than the category average of 1.0. Here the Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has shown very good performance in terms of risk adjusted returns.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Return Analysis

The Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -0.32%, 1.14 and 5.54 in last one, three and six months respectively. In the same period the category average return was -0.91%, 0.41% and 4.93% respectively.
  • Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has given a return of 4.63% in last one year. In the same period the Nifty Pharma TRI return was 3.12%. The fund has given 1.51% more return than the benchmark return.
  • The fund has given a return of 27.91% in last three years and rank 1st out of eight funds in the category. In the same period the Nifty Pharma TRI return was 21.61%. The fund has given 6.3% more return than the benchmark return.
  • Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund has given a return of 19.76% in last five years and category average returns is 17.9% in same period. The fund ranked 1.0st out of eight funds in the category. In the same period the Nifty Pharma TRI return was 14.04%. The fund has given 5.72% more return than the benchmark return.
  • The fund has given a SIP return of 10.61% in last one year whereas category average SIP return is 4.69%. The fund one year return rank in the category is 3rd in 13 funds
  • The fund has SIP return of 25.18% in last three years and ranks 1st in 8 funds. The fund has given the highest SIP return in the category in last three years.
  • The fund has SIP return of 21.33% in last five years whereas category average SIP return is 18.05%.

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Risk Analysis

  • The fund has a standard deviation of 15.74 and semi deviation of 11.35. The category average standard deviation is 15.53 and semi deviation is 10.78.
  • The fund has a Value at Risk (VaR) of -15.96 and a maximum drawdown of -15.77. The category average VaR is -16.15 and the maximum drawdown is -14.76. The fund has a beta of 0.89 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -0.39 2.81
    -1.01
    		-1.79 | -0.09 3 | 12 Very Good
    3M Return % 0.90 4.79
    0.09
    		-1.09 | 1.13 3 | 13 Very Good
    6M Return % 5.08 7.96
    4.26
    		-1.94 | 8.01 3 | 13 Very Good
    1Y Return % 3.75 3.12
    -0.50
    		-7.34 | 5.07 3 | 13 Very Good
    3Y Return % 26.80 21.61
    22.29
    		20.30 | 26.80 1 | 8 Very Good
    5Y Return % 18.70 14.04
    16.48
    		14.38 | 18.70 1 | 8 Very Good
    7Y Return % 22.09 15.04
    20.27
    		19.01 | 22.09 1 | 7 Very Good
    1Y SIP Return % 9.67
    3.34
    		-25.71 | 10.70 3 | 13 Very Good
    3Y SIP Return % 24.08
    18.67
    		12.89 | 24.08 1 | 8 Very Good
    5Y SIP Return % 20.30
    16.66
    		14.68 | 20.30 1 | 8 Very Good
    7Y SIP Return % 22.59
    20.07
    		19.06 | 22.59 1 | 7 Very Good
    Standard Deviation 15.74
    15.53
    		14.08 | 16.52 4 | 8 Good
    Semi Deviation 11.35
    10.78
    		9.82 | 11.37 7 | 8 Poor
    Max Drawdown % -15.77
    -14.76
    		-16.36 | -12.33 7 | 8 Poor
    VaR 1 Y % -15.96
    -16.15
    		-19.03 | -13.05 3 | 8 Good
    Average Drawdown % -5.64
    -5.69
    		-7.44 | -4.37 5 | 8 Average
    Sharpe Ratio 1.25
    1.00
    		0.81 | 1.25 1 | 8 Very Good
    Sterling Ratio 1.03
    0.89
    		0.79 | 1.08 2 | 8 Very Good
    Sortino Ratio 0.65
    0.54
    		0.44 | 0.66 2 | 8 Very Good
    Jensen Alpha % 8.80
    4.59
    		1.34 | 8.80 1 | 8 Very Good
    Treynor Ratio 0.22
    0.18
    		0.14 | 0.22 2 | 8 Very Good
    Modigliani Square Measure % 28.39
    23.94
    		20.31 | 28.70 2 | 8 Very Good
    Alpha % 6.72
    1.97
    		-1.14 | 6.72 1 | 8 Very Good
    Return data last Updated On : Dec. 4, 2025.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2025
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -0.32 2.81 -0.91 -1.66 | -0.01 3 | 12 Very Good
    3M Return % 1.14 4.79 0.41 -0.84 | 1.47 3 | 13 Very Good
    6M Return % 5.54 7.96 4.93 -1.15 | 8.94 4 | 13 Very Good
    1Y Return % 4.63 3.12 0.79 -5.81 | 6.47 3 | 13 Very Good
    3Y Return % 27.91 21.61 23.74 21.91 | 27.91 1 | 8 Very Good
    5Y Return % 19.76 14.04 17.90 16.01 | 19.76 1 | 8 Very Good
    7Y Return % 23.35 15.04 21.75 20.07 | 23.45 2 | 7 Very Good
    1Y SIP Return % 10.61 4.69 -24.55 | 12.63 3 | 13 Very Good
    3Y SIP Return % 25.18 20.14 14.57 | 25.18 1 | 8 Very Good
    5Y SIP Return % 21.33 18.05 16.26 | 21.33 1 | 8 Very Good
    7Y SIP Return % 23.74 21.54 20.17 | 23.74 1 | 7 Very Good
    Standard Deviation 15.74 15.53 14.08 | 16.52 4 | 8 Good
    Semi Deviation 11.35 10.78 9.82 | 11.37 7 | 8 Poor
    Max Drawdown % -15.77 -14.76 -16.36 | -12.33 7 | 8 Poor
    VaR 1 Y % -15.96 -16.15 -19.03 | -13.05 3 | 8 Good
    Average Drawdown % -5.64 -5.69 -7.44 | -4.37 5 | 8 Average
    Sharpe Ratio 1.25 1.00 0.81 | 1.25 1 | 8 Very Good
    Sterling Ratio 1.03 0.89 0.79 | 1.08 2 | 8 Very Good
    Sortino Ratio 0.65 0.54 0.44 | 0.66 2 | 8 Very Good
    Jensen Alpha % 8.80 4.59 1.34 | 8.80 1 | 8 Very Good
    Treynor Ratio 0.22 0.18 0.14 | 0.22 2 | 8 Very Good
    Modigliani Square Measure % 28.39 23.94 20.31 | 28.70 2 | 8 Very Good
    Alpha % 6.72 1.97 -1.14 | 6.72 1 | 8 Very Good
    Return data last Updated On : Dec. 4, 2025.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2025
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund NAV Regular Growth Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund NAV Direct Growth
    04-12-2025 40.35 43.61
    03-12-2025 40.22 43.47
    02-12-2025 40.25 43.5
    01-12-2025 40.27 43.52
    28-11-2025 40.53 43.79
    27-11-2025 40.45 43.71
    26-11-2025 40.51 43.77
    25-11-2025 40.11 43.33
    24-11-2025 39.9 43.11
    21-11-2025 40.17 43.4
    20-11-2025 40.38 43.62
    19-11-2025 40.45 43.71
    18-11-2025 40.52 43.78
    17-11-2025 40.81 44.08
    14-11-2025 40.72 43.98
    13-11-2025 40.64 43.9
    12-11-2025 40.48 43.73
    11-11-2025 40.07 43.29
    10-11-2025 40.14 43.36
    07-11-2025 39.94 43.14
    06-11-2025 40.11 43.32
    04-11-2025 40.51 43.75

    Fund Launch Date: 25/Jun/2018
    Fund Category: Pharma Fund
    Investment Objective: To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
    Fund Description: An Open Ended Equity Scheme following Pharma, Healthcare, Diagnostic and allied Theme
    Fund Benchmark: S&P BSE Healthcare Total Return Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.